Thermo Fisher Scientific Inc.
TMO
$424.40
-$2.26-0.53%
NYSE
| 12/31/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.68% | 0.23% | -1.37% | -3.41% | -4.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.68% | 0.23% | -1.37% | -3.41% | -4.93% |
| Cost of Revenue | 1.24% | 0.27% | -3.51% | -6.19% | -5.45% |
| Gross Profit | 9.72% | 0.16% | 1.85% | 0.93% | -4.15% |
| SG&A Expenses | 3.96% | 2.06% | 1.68% | 2.51% | -3.81% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 2,900.00% | -- | -- | -- | -- |
| Total Operating Expenses | 2.69% | 1.00% | -2.19% | -4.07% | -5.51% |
| Operating Income | 13.56% | -3.14% | 2.75% | 0.06% | -2.21% |
| Income Before Tax | 13.51% | -1.09% | 18.95% | 20.55% | -0.46% |
| Income Tax Expenses | 12.78% | 86.79% | 146.15% | 510.87% | -23.12% |
| Earnings from Continuing Operations | 13.57% | -3.83% | 14.10% | 3.10% | 2.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -75.00% | -- | -500.00% | -33.33% | 1,100.00% |
| Net Income | 12.27% | -4.96% | 13.74% | 3.03% | 3.43% |
| EBIT | 13.56% | -3.14% | 2.75% | 0.06% | -2.21% |
| EBITDA | 6.29% | -6.40% | -0.57% | -0.85% | -1.87% |
| EPS Basic | 13.74% | -3.96% | 14.93% | 4.10% | 4.50% |
| Normalized Basic EPS | 16.60% | -2.88% | 5.23% | 9.02% | 0.42% |
| EPS Diluted | 13.81% | -3.85% | 15.10% | 4.22% | 5.38% |
| Normalized Diluted EPS | 16.60% | -2.88% | 5.50% | 9.02% | 0.67% |
| Average Basic Shares Outstanding | -1.29% | -1.04% | -1.04% | -1.04% | -1.02% |
| Average Diluted Shares Outstanding | -1.29% | -1.03% | -1.29% | -1.03% | -1.27% |
| Dividend Per Share | 11.43% | 11.43% | 11.43% | 11.43% | 16.67% |
| Payout Ratio | -0.02% | 0.17% | -0.03% | 0.12% | 0.12% |